Dr. Mark Mercola

Biography

Mark Mercola is a Professor at Stanford University with expertise in Cardiovascular Medicine and Chemical Systems Biology. He completed his postdoctoral training at the Dana-Farber Cancer Institute, Harvard Medical School, and served as faculty in the Department of Cell Biology at Harvard Medical School for twelve years. Before relocating to Stanford in 2015, he worked at the Sanford-Burnham-Prebys Institute and the Department of Bioengineering at the University of California, San Diego. His research focuses on identifying factors responsible for heart formation, with a significant contribution being the discovery of Wnt inhibition as a critical step in cardiogenesis, providing a conceptual foundation for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has pioneered the use of patient-specific iPSC-cardiomyocytes for disease modeling and drug development, developing high-throughput assays to discover druggable targets that preserve cardiac function and promote regeneration after ischemic injury. Mercola co-established the Conrad Prebys Drug Discovery Center in San Diego and operates large screening centers under the NIH Molecular Libraries screening initiative. He has received the NIH MERIT award for his work on heart formation and holds numerous patents related to engineered proteins and stem cell applications. Mercola serves on multiple editorial advisory boards and is funded by several prestigious organizations, including the NIH and the California Institute for Regenerative Medicine.

Research Interests

Courses